Personnel
Dr. Bob Tepper, president of R&D, to leave Millennium
Published in Cancer Weekly, January 9th, 2007
Tepper was one of the founding executives of Millennium in 1994 and has steered the company through its expansion from a drug discovery company to a fully-integrated biopharmaceutical company with nine novel molecules in the clinic and a market-leading product, Velcadae (bortezomib) for Injection, for relapsed multiple myeloma and mantle cell lymphoma.
"Bob was one of a small group of people who had a vision for forming a new company that could make a difference in the way medicine is discovered to change the lives...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
Source: Cancer Weekly (2007-01-09)
More Articles from Cancer Weekly
- Cancer Research
Run amok enzyme causes the same problems in both humans and fruit flies - Cancer Therapy
Allergy drug slows pancreatic tumor growth, enhances chemotherapy in preclinical studies - Cancer Therapy
Introgen announces new clinical data confirming Advexin survival benefit - Cancer Gene Therapy
Data on cancer gene therapy discussed by researchers at Fudan University, Department of Pharmaceutics - Cancer Gene Therapy
Data on cancer gene therapy published by researchers at Central Hospital - Cancer Gene Therapy
Data on cancer gene therapy published by researchers at University of Medicine - More from this issue of Cancer Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
